The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
LUNG-IST-127: A pilot phase II study of maintenance cabozantinib plus pembrolizumab for patients with metastatic squamous non-small cell lung cancer (sqNSCLC) with disease control following induction therapy.
 
Ryan Huu-Tuan Nguyen
Consulting or Advisory Role - Merck
Research Funding - Exelixis
 
Lucia Notardonato
No Relationships to Disclose
 
Alicia Hulbert
No Relationships to Disclose
 
Apurva Mallisetty
No Relationships to Disclose
 
Frank Weinberg
Consulting or Advisory Role - Jazz Pharmaceuticals; Regeneron
Speakers' Bureau - Amgen
 
Israel Rubinstein
No Relationships to Disclose
 
Irene Juson
No Relationships to Disclose
 
Cindy Chan
No Relationships to Disclose
 
Li C. Liu
No Relationships to Disclose
 
Zhengjia Chen
No Relationships to Disclose
 
Lawrence Eric Feldman
Research Funding - E.R. Squibb Sons, LLC (Inst); Genentech (Inst); Roche (Inst)